Cure My Disease
Don't miss your cure!
Clinical trials sponsored by Dreamhawk Vision Biotech, Inc., explained in plain language.
This Phase 2 trial tested an experimental eye drop called SHJ002 in 85 adults with dry eye disease. The drops are designed to block a specific microRNA linked to inflammation. Researchers measured changes in corneal staining and symptom scores over 84 days to see if the drops are…
Phase: PHASE2 • Sponsor: Dreamhawk Vision Biotech, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 07:54 UTC